Zobrazeno 1 - 4
of 4
pro vyhledávání: '"R H, Lachmann"'
Autor:
A. T. van der Ploeg, M. Ую Kruijshaar, A. Toscano, P. Laforet, C. Angelini, R. H. Lachmann, S. I. Pascual Pascual, M. Roberts, K. Rosler, T. Stulnig, P. A. van Doorn, P.Y. K. Van den Bergh, J. Vissing, B. Schoser
Publikováno v:
Нервно-мышечные болезни, Vol 8, Iss 4, Pp 19-34 (2019)
Externí odkaz:
https://doaj.org/article/ce2d7bf9e8664d6a848167c86ae07198
Publikováno v:
Journal of intellectual disability research : JIDR. 57(6)
To quantify the costs and consequences of managing phenylketonuria (PKU) in the UK and to estimate the potential implications to the UK's National Health Service (NHS) of keeping patients on a phenylalanine-restricted diet for life.A computer-based m
Autor:
R H, Lachmann, S, Efstathiou
Publikováno v:
Current opinion in molecular therapeutics. 1(5)
In developing any viral gene delivery vector there are two fundamental problems which need to be addressed. Firstly, replication disabled vectors which will be safe for clinical use must be constructed, and secondly, strategies for obtaining appropri
Autor:
R H, Lachmann, S, Efstathiou
Publikováno v:
Clinical science (London, England : 1979). 96(6)
Gene therapy might provide a useful treatment for a number of neurological diseases and a great deal of effort is going into the development of vector systems which will allow the delivery of potentially therapeutic genes to terminally differentiated